# The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery

> **NCT00413244** · PHASE3 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 51 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** AndroGel 5 Grams
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00413244
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-11
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2017-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413244, "The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00413244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*